{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T02:06:45Z","timestamp":1791166005168,"version":"4.1.0"},"reference-count":58,"publisher":"Public Library of Science (PLoS)","issue":"2","license":[{"start":{"date-parts":[[2013,2,5]],"date-time":"2013-02-05T00:00:00Z","timestamp":1360022400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0055373","type":"journal-article","created":{"date-parts":[[2013,2,5]],"date-time":"2013-02-05T22:42:23Z","timestamp":1360104143000},"page":"e55373","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":30,"title":["Treatment Outcomes of Treatment-Na\u00efve Hepatitis C Patients Co-Infected with HIV: A Systematic Review and Meta-Analysis of Observational Cohorts"],"prefix":"10.1371","volume":"8","author":[{"given":"Anna","family":"Davies","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kasha P.","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zara","family":"Shubber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philipp","family":"duCros","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edward J.","family":"Mills","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Graham","family":"Cooke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nathan","family":"Ford","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2013,2,5]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1002\/hep.510300409","article-title":"Liver fibrosis progression in human immunodeficiency virus and hepatitis C virus coinfected patients. The Multivirc Group","volume":"30","author":"Y Benhamou","year":"1999","journal-title":"Hepatology"},{"key":"ref2","unstructured":"Rockstroh J, Konopnicki D, Soriano V (2004) Hepatitis B and hepatitis C in the EuroSIDA cohort: prevalence and effect on mortality, AIDS, progression and response to HAART. 11th Conference on Retroviruses and Opportunistic Infections, San Francisco, CA, USA, Feb 8\u201311. Abstract 799."},{"key":"ref3","doi-asserted-by":"crossref","unstructured":"Singal AG, Volk ML, Jensen D, Di Bisceglie AM, Schoenfeld PS (2010) A sustained viral response is associated with reduced liver-related morbidity and mortality in patients with hepatitis C virus. Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association 8: 280\u2013288, 288 e281.","DOI":"10.1016\/j.cgh.2009.11.018"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1001\/jama.2012.7844","article-title":"Relationship of liver disease stage and antiviral therapy with liver-related events and death in adults coinfected with HIV\/HCV","volume":"308","author":"BN Limketkai","year":"2012","journal-title":"JAMA : the journal of the American Medical Association"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"e34548","DOI":"10.1371\/journal.pone.0034548","article-title":"Treatment of hepatitis C as prevention: a modeling case study in Vietnam","volume":"7","author":"N Durier","year":"2012","journal-title":"PloS one"},{"key":"ref6","doi-asserted-by":"crossref","unstructured":"Iorio A, Marchesini E, Awad T, Gluud LL (2010) Antiviral treatment for chronic hepatitis C in patients with human immunodeficiency virus. Cochrane database of systematic reviews: CD004888.","DOI":"10.1002\/14651858.CD004888.pub2"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"540","DOI":"10.2471\/BLT.11.097147","article-title":"Chronic hepatitis C treatment outcomes in low- and middle-income countries: a systematic review and meta-analysis","volume":"90","author":"N Ford","year":"2012","journal-title":"Bulletin of the World Health Organization"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"d7020","DOI":"10.1136\/bmj.d7020","article-title":"Why do the results of randomised and observational studies differ","volume":"343","author":"JP Vandenbroucke","year":"2011","journal-title":"BMJ"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"b2700","DOI":"10.1136\/bmj.b2700","article-title":"The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration","volume":"339","author":"A Liberati","year":"2009","journal-title":"BMJ"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1214\/aoms\/1177729756","article-title":"Transformations related to the angular and the square root","volume":"21","author":"MF Freeman","year":"1950","journal-title":"Ann Inst Stat Mathematics"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/0197-2456(86)90046-2","article-title":"Meta-analysis in clinical trials","volume":"7","author":"R DerSimonian","year":"1986","journal-title":"Controlled clinical trials"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1136\/bmj.327.7414.557","article-title":"Measuring inconsistency in meta-analyses","volume":"327","author":"JP Higgins","year":"2003","journal-title":"BMJ"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1093\/jac\/dkn013","article-title":"The use of trough ribavirin concentration to predict sustained virological response and haematological toxicity in HIV\/HCV-co-infected patients treated with ribavirin and pegylated interferon","volume":"61","author":"D Aguilar Marucco","year":"2008","journal-title":"The Journal of antimicrobial chemotherapy"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"91","DOI":"10.3851\/IMP1492","article-title":"The influence of abacavir and other antiretroviral agents on virological response to HCV therapy among antiretroviral-treated HIV-infected patients","volume":"15","author":"VK Amorosa","year":"2010","journal-title":"Antiviral therapy"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"e52","DOI":"10.1111\/j.1365-2893.2010.01358.x","article-title":"Very early prediction of response to HCV treatment with PEG-IFN-alfa-2a and ribavirin in HIV\/HCV-coinfected patients","volume":"18","author":"ES Araujo","year":"2011","journal-title":"Journal of viral hepatitis"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1097\/QAI.0b013e3181be7249","article-title":"Hepatitis C viral kinetics during treatment with peg IFN-alpha-2b in HIV\/HCV coinfected patients as a function of baseline CD4+ T-cell counts","volume":"52","author":"NU Avidan","year":"2009","journal-title":"Journal of acquired immune deficiency syndromes"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"2843","DOI":"10.1093\/jac\/dkr362","article-title":"Effect of accompanying antiretroviral drugs on virological response to pegylated interferon and ribavirin in patients co-infected with HIV and hepatitis C virus","volume":"66","author":"J Berenguer","year":"2011","journal-title":"The Journal of antimicrobial chemotherapy"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1086\/655780","article-title":"Proteome-wide anti-hepatitis C virus (HCV) and anti-HIV antibody profiling for predicting and monitoring the response to HCV therapy in HIV-coinfected patients","volume":"202","author":"PD Burbelo","year":"2010","journal-title":"The Journal of infectious diseases"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1111\/j.1468-1293.2009.00729.x","article-title":"Impact of hyperglycaemia and cholesterol levels on the outcome of hepatitis C virus (HCV) treatment in HIV\/HCV-coinfected patients","volume":"10","author":"M Cesari","year":"2009","journal-title":"HIV medicine"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"207","DOI":"10.2147\/TCRM.S9951","article-title":"Equitable access to HCV care in HIV-HCV co-infection can be achieved despite barriers to health care provision","volume":"6","author":"CL Cooper","year":"2010","journal-title":"Therapeutics and clinical risk management"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"S349","DOI":"10.1086\/427452","article-title":"Challenges in the treatment of patients coinfected with HIV and hepatitis C virus: need for team care","volume":"40","author":"CA Fleming","year":"2005","journal-title":"Clinical infectious diseases : an official publication of the Infectious Diseases Society of America"},{"key":"ref22","first-page":"w13055","article-title":"Treatment of hepatitis C in HCV mono-infected and in HIV-HCV co-infected patients: an open-labelled comparison study","volume":"140","author":"JJ Gonvers","year":"2010","journal-title":"Swiss medical weekly"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1155\/2012\/384630","article-title":"Optimizing hepatitis C therapy in HIV\/hepatitis C virus (HCV) coinfected patients: Analysis of HCV viral kinetics on treatment","volume":"23","author":"PD James","year":"2008","journal-title":"Canadian Journal of Infectious Diseases and Medical Microbiology"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1097\/QAD.0b013e3282f7067e","article-title":"Similar hepatitis C virus RNA kinetics in HIV\/hepatitis C virus monoinfected genotype 2 or 3 matched controls during hepatitis C virus combination therapy","volume":"22","author":"O Karlstrom","year":"2008","journal-title":"AIDS"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1258\/ijsa.2011.010416","article-title":"High uptake of hepatitis C virus treatment in HIV\/hepatitis C virus co-infected patients attending an integrated HIV\/hepatitis C virus clinic","volume":"22","author":"J Kieran","year":"2011","journal-title":"International journal of STD & AIDS"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.antiviral.2011.02.013","article-title":"HCV RNA decline in the first 24 h exhibits high negative predictive value of sustained virologic response in HIV\/HCV genotype 1 co-infected patients treated with peginterferon and ribavirin","volume":"90","author":"N Laufer","year":"2011","journal-title":"Antiviral research"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/S1665-2681(19)31653-9","article-title":"Sustained virological response according to the type of early virological response in HCV and HCV\/HIV","volume":"9","author":"PR Lerias de Almeida","year":"2010","journal-title":"Annals of hepatology"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"e28115","DOI":"10.1371\/journal.pone.0028115","article-title":"Influence of IL28B polymorphisms on response to a lower-than-standard dose peg-IFN-alpha 2a for genotype 3 chronic hepatitis C in HIV-coinfected patients","volume":"7","author":"LF Lopez-Cortes","year":"2012","journal-title":"PloS one"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"2204","DOI":"10.1093\/jac\/dkq272","article-title":"Changes in liver stiffness in patients with chronic hepatitis C with and without HIV co-infection treated with pegylated interferon plus ribavirin","volume":"65","author":"J Macias","year":"2010","journal-title":"The Journal of antimicrobial chemotherapy"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"e32028","DOI":"10.1371\/journal.pone.0032028","article-title":"Circulating sCD14 is associated with virological response to pegylated-interferon-alpha\/ribavirin treatment in HIV\/HCV co-infected patients","volume":"7","author":"G Marchetti","year":"2012","journal-title":"PloS one"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1086\/591707","article-title":"Clinical outcomes of hepatitis C treatment in a prison setting: feasibility and effectiveness for challenging treatment populations","volume":"47","author":"DS Maru","year":"2008","journal-title":"Clinical infectious diseases : an official publication of the Infectious Diseases Society of America"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"2361","DOI":"10.1097\/QAD.0b013e32801086da","article-title":"Limited effectiveness of antiviral treatment for hepatitis C in an urban HIV clinic","volume":"20","author":"SH Mehta","year":"2006","journal-title":"AIDS"},{"key":"ref33","first-page":"389","article-title":"Treatment of chronic hepatitis C in patients with human immunodeficiency virus (HIV) with weekly peginterferon alpha-2b plus ribavirin: a multi-centred Belgian study","volume":"72","author":"P Michielsen","year":"2009","journal-title":"Acta gastro-enterologica Belgica"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"e84","DOI":"10.1086\/605677","article-title":"Efficacy and safety of pegylated interferon plus ribavirin in HIV and hepatitis C virus-coinfected patients with advanced immunosuppression","volume":"49","author":"JA Mira","year":"2009","journal-title":"Clinical infectious diseases : an official publication of the Infectious Diseases Society of America"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1097\/MEG.0b013e328341ef54","article-title":"Hepatitis C virus treatment rates and outcomes in HIV\/hepatitis C virus co-infected individuals at an urban HIV clinic","volume":"23","author":"MC Murray","year":"2011","journal-title":"European journal of gastroenterology & hepatology"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"1783","DOI":"10.1097\/00002030-200109280-00006","article-title":"Chronic hepatitis C in HIV infection: feasibility and sustained efficacy of therapy with interferon alfa-2b and tribavirin","volume":"15","author":"G Nasti","year":"2001","journal-title":"AIDS"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1016\/j.jhep.2011.11.008","article-title":"Prediction of response to pegylated interferon plus ribavirin in HIV\/hepatitis C virus (HCV)-coinfected patients using HCV genotype, IL28B variations, and HCV-RNA load","volume":"56","author":"K Neukam","year":"2012","journal-title":"Journal of hepatology"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"1523","DOI":"10.1002\/jmv.21227","article-title":"Serum concentrations of ribavirin and pegylated interferon and viral responses in patients infected with HIV and HCV","volume":"80","author":"F Nicot","year":"2008","journal-title":"Journal of medical virology"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"2001","DOI":"10.1097\/QAD.0b013e32833bedc8","article-title":"The cytotoxic lymphocyte antigen 4 polymorphisms affect response to hepatitis C virus-specific therapy in HIV(+) patients with acute and chronic hepatitis C virus co-infection","volume":"24","author":"HD Nischalke","year":"2010","journal-title":"AIDS"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1310\/50JB-VNBB-7HRG-7GUR","article-title":"Efficacy and tolerance of HCV treatment in HIV-HCV coinfected patients: the potential interaction of PI treatment","volume":"4","author":"I Poizot-Martin","year":"2003","journal-title":"HIV clinical trials"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1177\/135965350801300815","article-title":"IP-10 correlates with hepatitis C viral load, hepatic inflammation and fibrosis and predicts hepatitis C virus relapse or non-response in HIV-HCV coinfection","volume":"13","author":"T Reiberger","year":"2008","journal-title":"Antiviral therapy"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"815","DOI":"10.3851\/IMP1831","article-title":"Considerable under-treatment of chronic HCV infection in HIV patients despite acceptable sustained virological response rates in a real-life setting","volume":"16","author":"T Reiberger","year":"2011","journal-title":"Antiviral therapy"},{"key":"ref43","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1007\/s15010-008-7319-5","article-title":"Therapeutical aspects and outcome of HIV\/HCV coinfected patients treated with pegylated interferon plus ribavirin in an Italian cohort","volume":"36","author":"E Righi","year":"2008","journal-title":"Infection"},{"key":"ref44","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/j.clim.2010.11.001","article-title":"The basal activation state of DC subsets correlates with anti-HCV treatment outcome in HCV\/HIV co-infected patients","volume":"138","author":"A Sacchi","year":"2011","journal-title":"Clinical immunology"},{"key":"ref45","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1089\/aid.2006.22.315","article-title":"Efficacy and safety of pegylated interferon-alpha2b plus ribavirin for the treatment of chronic hepatitis C in HIV-infected patients","volume":"22","author":"M Santin","year":"2006","journal-title":"AIDS research and human retroviruses"},{"key":"ref46","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1016\/j.jinf.2006.11.010","article-title":"Impact of peginterferon alpha-2b and ribavirin treatment on liver tissue in patients with HCV or HCV-HIV co-infection","volume":"54","author":"R Sarmento-Castro","year":"2007","journal-title":"The Journal of infection"},{"key":"ref47","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.drugalcdep.2010.11.016","article-title":"Treatment for hepatitis C virus genotype 1 infection in HIV-infected individuals on methadone maintenance therapy","volume":"116","author":"LE Taylor","year":"2011","journal-title":"Drug and alcohol dependence"},{"key":"ref48","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1111\/j.1468-1293.2007.00505.x","article-title":"Improved cognitive function as a consequence of hepatitis C virus treatment","volume":"8","author":"HH Thein","year":"2007","journal-title":"HIV medicine"},{"key":"ref49","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1097\/QAD.0b013e3283350f7c","article-title":"Ability of treatment week 12 viral response to predict long-term outcome in genotype 1 hepatitis C virus\/HIV coinfected patients","volume":"24","author":"E Van den Eynde","year":"2010","journal-title":"AIDS"},{"key":"ref50","doi-asserted-by":"crossref","first-page":"903480","DOI":"10.1155\/2011\/903480","article-title":"Patient Characteristics Associated with HCV Treatment Adherence, Treatment Completion, and Sustained Virologic Response in HIV Coinfected Patients","volume":"2011","author":"G Wagner","year":"2011","journal-title":"AIDS research and treatment"},{"key":"ref51","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1111\/j.1872-034X.2009.00517.x","article-title":"Chronic hepatitis C in patients co-infected with human immunodeficiency virus in Japan: a retrospective multicenter analysis","volume":"39","author":"H Yotsuyanagi","year":"2009","journal-title":"Hepatology research : the official journal of the Japan Society of Hepatology"},{"key":"ref52","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1177\/135965350601100207","article-title":"Eligibility for and outcome of hepatitis C treatment of HIV-coinfected individuals in clinical practice: the Swiss HIV cohort study","volume":"11","author":"AS Zinkernagel","year":"2006","journal-title":"Antiviral therapy"},{"key":"ref53","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1002\/hep.510240201","article-title":"An algorithm for the grading of activity in chronic hepatitis C. The METAVIR Cooperative Study Group","volume":"24","author":"P Bedossa","year":"1996","journal-title":"Hepatology"},{"key":"ref54","first-page":"729","article-title":"Institute of Medicine recommendations for the prevention and control of hepatitis B and C. Hepatology","volume":"51","author":"AE Mitchell","year":"2010"},{"key":"ref55","unstructured":"Scaglione SJ, Lok AS (2012) Effectiveness of hepatitis B treatment in clinical practice. Gastroenterology 142: 1360\u20131368 e1361."},{"key":"ref56","doi-asserted-by":"crossref","unstructured":"Gluud LL, Marchesini E, Iorio A (2009) Peginterferon plus ribavirin for chronic hepatitis C in patients with human immunodeficiency virus. The American journal of gastroenterology 104: 2335\u20132341; quiz 2342.","DOI":"10.1038\/ajg.2009.311"},{"key":"ref57","doi-asserted-by":"crossref","first-page":"1915","DOI":"10.1097\/00002030-200209270-00008","article-title":"Immune recovery is associated with persistent rise in hepatitis C virus RNA, infrequent liver test flares, and is not impaired by hepatitis C virus in co-infected subjects","volume":"16","author":"RT Chung","year":"2002","journal-title":"AIDS"},{"key":"ref58","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1086\/630205","article-title":"Rate and timing of hepatitis C virus relapse after a successful course of pegylated interferon plus ribavirin in HIV-infected and HIV-uninfected patients","volume":"49","author":"J Medrano","year":"2009","journal-title":"Clinical infectious diseases : an official publication of the Infectious Diseases Society of America"}],"container-title":["PLoS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0055373","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,6,29]],"date-time":"2023-06-29T07:33:11Z","timestamp":1688023991000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0055373"}},"subtitle":[],"editor":[{"given":"Ravi","family":"Jhaveri","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2013,2,5]]},"references-count":58,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2013,2,5]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0055373","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,2,5]]}}}